GenMark Diagnostics, Inc. (GNMK) Forms $7.07 Double Bottom; Dreamworks Animation SKG, Inc. (DWA) Had 1 Analysts Last Week

GenMark Diagnostics, Inc. (GNMK) formed double bottom with $6.79 target or 4.00% below today’s $7.07 share price. GenMark Diagnostics, Inc. (GNMK) has $391.77 million valuation. The stock increased 3.82% or $0.26 during the last trading session, reaching $7.07. About 586,646 shares traded or 78.28% up from the average. GenMark Diagnostics, Inc. (NASDAQ:GNMK) has declined 59.05% since May 5, 2017 and is downtrending. It has underperformed by 70.60% the S&P500.

Among 12 analysts covering Dreamworks Animation Skg Inc. (NASDAQ:DWA), 1 have Buy rating, 3 Sell and 8 Hold. Therefore 8% are positive. Dreamworks Animation Skg Inc. had 23 analyst reports since July 23, 2015 according to SRatingsIntel. Pacific Crest downgraded Dreamworks Animation SKG, Inc. (NASDAQ:DWA) on Friday, April 29 to “Sector Weight” rating. The stock has “Neutral” rating by B. Riley & Co on Monday, January 4. The firm has “Sell” rating given on Tuesday, August 25 by Topeka Capital Markets. The rating was upgraded by Topeka Capital Markets on Tuesday, May 3 to “Hold”. The firm has “Hold” rating by Stifel Nicolaus given on Monday, May 2. The rating was downgraded by FBR Capital on Monday, May 2 to “Mkt Perform”. The stock has “Neutral” rating by BTIG Research on Thursday, April 28. B. Riley & Co upgraded Dreamworks Animation SKG, Inc. (NASDAQ:DWA) on Monday, August 24 to “Buy” rating. Pacific Crest initiated it with “Overweight” rating and $31 target in Tuesday, March 29 report. Goldman Sachs upgraded Dreamworks Animation SKG, Inc. (NASDAQ:DWA) rating on Friday, April 29. Goldman Sachs has “Neutral” rating and $30 target. See Dreamworks Animation SKG, Inc. (NASDAQ:DWA) latest ratings:

Since January 23, 2018, it had 1 buying transaction, and 26 selling transactions for $311,956 activity. Another trade for 6,275 shares valued at $26,167 was made by Mendel Scott on Friday, February 23. Mitchell Brian Andrew sold $4,017 worth of stock. The insider McNally James B. sold $4,387. Kayyem Jon Faiz sold $759 worth of stock. Another trade for 1,996 shares valued at $8,723 was made by Stier Eric on Tuesday, February 20. Shares for $20,479 were sold by Williams Jennifer Anne. $28,772 worth of stock was sold by MASSARANY HANY on Tuesday, February 20.

Among 6 analysts covering Genmark Diagnostics (NASDAQ:GNMK), 5 have Buy rating, 0 Sell and 1 Hold. Therefore 83% are positive. Genmark Diagnostics has $1700 highest and $8 lowest target. $11.20’s average target is 58.42% above currents $7.07 stock price. Genmark Diagnostics had 21 analyst reports since October 14, 2015 according to SRatingsIntel. The stock of GenMark Diagnostics, Inc. (NASDAQ:GNMK) earned “Buy” rating by Needham on Friday, January 19. Raymond James downgraded the stock to “Market Perform” rating in Friday, November 3 report. The rating was maintained by Canaccord Genuity with “Buy” on Monday, October 30. Needham maintained the shares of GNMK in report on Monday, June 12 with “Buy” rating. The stock of GenMark Diagnostics, Inc. (NASDAQ:GNMK) has “Buy” rating given on Monday, August 7 by Canaccord Genuity. The stock has “Buy” rating by Canaccord Genuity on Monday, June 12. The rating was maintained by Canaccord Genuity on Friday, November 3 with “Buy”. The stock of GenMark Diagnostics, Inc. (NASDAQ:GNMK) has “Buy” rating given on Monday, September 25 by Canaccord Genuity. The company was maintained on Wednesday, October 18 by Needham. The stock of GenMark Diagnostics, Inc. (NASDAQ:GNMK) has “Outperform” rating given on Friday, September 16 by Cowen & Co.

Investors sentiment decreased to 1.26 in Q4 2017. Its down 0.62, from 1.88 in 2017Q3. It is negative, as 14 investors sold GenMark Diagnostics, Inc. shares while 21 reduced holdings. 18 funds opened positions while 26 raised stakes. 53.33 million shares or 5.73% less from 56.57 million shares in 2017Q3 were reported. New York-based D E Shaw And Communications has invested 0% in GenMark Diagnostics, Inc. (NASDAQ:GNMK). 53,763 were accumulated by Wells Fargo Mn. Sg Americas Lc reported 0% in GenMark Diagnostics, Inc. (NASDAQ:GNMK). Alphaone Invest Limited Liability Corporation has 8,900 shares. Blair William & Il has 93,266 shares for 0% of their portfolio. Thrivent Fincl For Lutherans holds 588,970 shares. Jpmorgan Chase & stated it has 4.77 million shares. Cannell Peter B has invested 0% in GenMark Diagnostics, Inc. (NASDAQ:GNMK). Weiss Multi accumulated 151,000 shares. Victory Cap Incorporated, Ohio-based fund reported 6,439 shares. Prelude Cap Mgmt Ltd Liability Company holds 0% in GenMark Diagnostics, Inc. (NASDAQ:GNMK) or 600 shares. Ironwood Financial Lc holds 3,550 shares. Parallax Volatility Advisers L P, a California-based fund reported 7,686 shares. Blackrock reported 3.12 million shares. Parametric Port Assoc Llc holds 13,512 shares or 0% of its portfolio.

GenMark Diagnostics, Inc. (NASDAQ:GNMK) Institutional Positions Chart